Cushman & Wakefield has gotten torched over the last six months - since November 2024, its stock price has dropped 24.1% to $10.50 per share. This might have investors contemplating their next move.

Is now the time to buy Cushman & Wakefield, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Do We Think Cushman & Wakefield Will Underperform?

Even with the cheaper entry price, we're cautious about Cushman & Wakefield. Here are three reasons why you should be careful with CWK and a stock we'd rather own.

1. Long-Term Revenue Growth Disappoints

Reviewing a company’s long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last five years, Cushman & Wakefield grew its sales at a weak 1.8% compounded annual growth rate. This was below our standards.Cushman & Wakefield Quarterly Revenue

2. EPS Trending Down

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Sadly for Cushman & Wakefield, its EPS declined by 8.6% annually over the last five years while its revenue grew by 1.8%. This tells us the company became less profitable on a per-share basis as it expanded.Cushman & Wakefield Trailing 12-Month EPS (Non-GAAP)

3. Previous Growth Initiatives Haven’t Impressed

Growth gives us insight into a company’s long-term potential, but how capital-efficient was that growth? Enter ROIC, a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

Cushman & Wakefield historically did a mediocre job investing in profitable growth initiatives. Its five-year average ROIC was 6.4%, somewhat low compared to the best consumer discretionary companies that consistently pump out 25%+.Cushman & Wakefield Trailing 12-Month Return On Invested Capital

Final Judgment

We cheer for all companies serving everyday consumers, but in the case of Cushman & Wakefield, we’ll be cheering from the sidelines. After the recent drawdown, the stock trades at 9.4× forward P/E (or $10.50 per share). While this valuation is optically cheap, the potential downside is huge given its shaky fundamentals. There are better investments elsewhere. Let us point you toward the most dominant software business in the world.

Stocks We Like More Than Cushman & Wakefield

Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.

While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

View Comments